← back to search

Jiahui Li

Chinese University of Hong Kong · HK
Area of research
Immunology · Physiology
Research interest
Research interests include interferon and immune responses, Adipose Tissue and Metabolism, Immunotherapy and Immune Responses, and MicroRNA in disease regulation.
h-index
22
citations
1,506
works
79
NIH funding
primary concept
email

Recent publications

Endothelial STING-JAK1 interaction promotes tumor vasculature normalization and antitumor immunity
Journal of Clinical Investigation 2025cited by 21position: middledoi
CD38-targeted antibody-polymer drug conjugates for enhanced treatment of multiple myeloma
Biomaterials 2025cited by 8position: firstdoi
Effects and mechanisms of anti-diabetic dietary natural products: an updated review
Food & Function 2024cited by 31position: middledoi
Squalene-epoxidase-catalyzed 24(S),25-epoxycholesterol synthesis promotes trained-immunity-mediated antitumor activity
Cell Reports 2024cited by 20position: middledoi
Potentially harmful effects of micro-/nanoplastics on humans as well as protective actions of dietary natural products
Trends in Food Science & Technology 2024cited by 16position: middledoi
Bioactive compounds and health benefits of pomegranate: An updated narrative review
Food Bioscience 2023cited by 44position: middledoi
Bioactive Compounds, Health Benefits and Food Applications of Grape
Foods 2022cited by 188position: middledoi
Dietary sources, health benefits, and risks of caffeine
Critical Reviews in Food Science and Nutrition 2022cited by 101position: middledoi
Possible Effects and Mechanisms of Dietary Natural Products and Nutrients on Depression and Anxiety: A Narrative Review
Antioxidants 2022cited by 49position: middledoi
Crosslinking of CD38 Receptors Triggers Apoptosis of Malignant B Cells
Molecules 2021cited by 18position: middledoi
Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma
International Journal of Biological Sciences 2020cited by 146position: middledoi
Inflammatory IFIT3 renders chemotherapy resistance by regulating post-translational modification of VDAC2 in pancreatic cancer
Theranostics 2020cited by 60position: middledoi
Novel long non-coding RNA GACAT3 promotes gastric cancer cell proliferation through the IL-6/STAT3 signaling pathway
Tumor Biology 2016cited by 33position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Siyu Huang · Kunming Institute of Botany6 papers (2022–2024)Hua‐Bin Li · Liaocheng University6 papers (2022–2024)Dan-Dan Zhou · Nanjing Forestry University6 papers (2022–2024)Ruo-Gu Xiong · Sun Yat-sen University6 papers (2022–2024)Si-Xia Wu · Sun Yat-sen University5 papers (2022–2024)Ren‐You Gan · Hong Kong Polytechnic University5 papers (2022–2024)Ao Shang · University of Hong Kong5 papers (2022–2024)Adila Saimaiti · Sun Yat-sen University4 papers (2022–2023)Cai‐Ning Zhao · China Pharmaceutical University2 papers (2022–2022)C. Xie · Sun Yat-sen University2 papers (2024–2025)Jiyuan Yang · Nanjing Tech University2 papers (2021–2025)Yongxiang Liu · Shenyang Pharmaceutical University2 papers (2024–2025)Huanling Zhang · Key Laboratory of Guangdong Province2 papers (2024–2025)Guoyi Tang · Chinese University of Hong Kong2 papers (2024–2024)Jin Cheng · Xiamen University2 papers (2023–2024)Jindŕich Kopec̆ek · University of Utah2 papers (2021–2025)Xiaojun Xia · Zhejiang International Studies University2 papers (2024–2025)Qiongzhu Dong · Fudan University2 papers (2020–2020)Yue Zhao · University Hospital Cologne2 papers (2020–2020)Hakan Alakus · University Hospital Cologne2 papers (2020–2020)